Pharma company AstraZeneca has publicly released preclinical data from more than 50 of its medicines in order to find new drug combinations for cancer treatments. The data AstraZeneca released will be ...
AstraZeneca's ambitious $80 billion revenue goal by 2030 hinges on oncology growth and successful new drug launches, but faces patent expiries and fierce competition. While current financials and ...
AstraZeneca is keeping its options over expansion in Cambridge open by submitting fresh plans for a new conference centre and ...
Gov. Wes Moore and AstraZeneca announced plans Friday to invest $2 billion to expand AstraZeneca's manufacturing footprint in Maryland, marking the largest private capital investment in the state in ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results